IFACX
Price
$27.45
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Net Assets
149.58B
PASRX
Price
$23.02
Change
+$0.15 (+0.66%)
Updated
Sep 11 closing price
Net Assets
4.2B
Interact to see
Advertisement

IFACX vs PASRX

IFACX vs PASRX Comparison Chart in %
View a ticker or compare two or three
VS
IFACX vs. PASRX commentary
Sep 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFACX is a Hold and PASRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
IFACX has more cash in the bank: 150B vs. PASRX (4.2B). IFACX pays higher dividends than PASRX: IFACX (2.74) vs PASRX (1.46). IFACX was incepted earlier than PASRX: IFACX (26 years) vs PASRX (24 years). IFACX (1.31) is less costly to investors than PASRX (1.23). PASRX is a more actively managed with annual turnover of: 100.00 vs. IFACX (65.00). PASRX has a lower initial minimum investment than IFACX: PASRX (0) vs IFACX (250). PASRX annual gain was more profitable for investors over the last year : 9.16 vs. IFACX (4.08). IFACX return over 5 years is better than : 20.84 vs. PASRX (17.03).
IFACXPASRXIFACX / PASRX
Total Expense Ratio1.311.23107%
Annual Report Gross Expense Ratio1.311.23107%
Fund Existence26 years24 years-
Gain YTD8.10510.72676%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets150B4.2B3,571%
Annual Yield % from dividends2.741.46188%
Returns for 1 year4.089.1645%
Returns for 3 years35.3142.8382%
Returns for 5 years20.8417.03122%
Returns for 10 years52.8671.3874%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMVNX17.130.17
+1.00%
JHFunds2 Mid Value NAV
PRJCX29.930.28
+0.94%
PGIM Jennison Global Opportunities C
MKEFX22.150.20
+0.91%
BlackRock International Select Eq K
ADCIX24.830.21
+0.85%
American Century Disciplined Growth I
VEURX48.320.32
+0.67%
Vanguard European Stock Investor